Menu Search
Equities

CVS Health Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CVS*:MEX

CVS Health Corp

Actions
  • Price (MXN)1,303.11
  • Today's Change0.000 / 0.00%
  • Shares traded5.00
  • 1 Year change+17.44%
  • Beta0.4919
Data delayed at least 20 minutes, as of Feb 05 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

  • Revenue in USD (TTM)394.08bn
  • Net income in USD469.00m
  • Incorporated1996
  • Employees300.00k
  • Location
    CVS Health CorpOne Cvs Dr.WOONSOCKET 02895United StatesUSA
  • Phone+1 (401) 765-1500
  • Fax+1 (302) 655-5049
  • Websitehttps://cvshealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.